198 related articles for article (PubMed ID: 29206633)
1. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
2. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
3. A common MUC5B promoter polymorphism and pulmonary fibrosis.
Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
[TBL] [Abstract][Full Text] [Related]
4. Influence of MUC5B gene on antisynthetase syndrome.
López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
[TBL] [Abstract][Full Text] [Related]
5. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the promoter
Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
[TBL] [Abstract][Full Text] [Related]
7. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
Transpl Int; 2022; 35():10159. PubMed ID: 35651878
[TBL] [Abstract][Full Text] [Related]
8. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.
Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y
PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989
[TBL] [Abstract][Full Text] [Related]
9. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
Borie R; Crestani B; Dieude P; Nunes H; Allanore Y; Kannengiesser C; Airo P; Matucci-Cerinic M; Wallaert B; Israel-Biet D; Cadranel J; Cottin V; Gazal S; Peljto AL; Varga J; Schwartz DA; Valeyre D; Grandchamp B
PLoS One; 2013; 8(8):e70621. PubMed ID: 23940607
[TBL] [Abstract][Full Text] [Related]
10. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
Lee MG; Lee YH
Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
[TBL] [Abstract][Full Text] [Related]
12. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W
Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656
[TBL] [Abstract][Full Text] [Related]
13. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
14.
Joo YB; Ahn SM; Bang SY; Park Y; Hong SJ; Lee Y; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Yoo DH; Bae SC; Lee HS
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581384
[TBL] [Abstract][Full Text] [Related]
15. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
[TBL] [Abstract][Full Text] [Related]
16. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
17.
Mathai SK; Humphries S; Kropski JA; Blackwell TS; Powers J; Walts AD; Markin C; Woodward J; Chung JH; Brown KK; Steele MP; Loyd JE; Schwarz MI; Fingerlin T; Yang IV; Lynch DA; Schwartz DA
Thorax; 2019 Dec; 74(12):1131-1139. PubMed ID: 31558622
[TBL] [Abstract][Full Text] [Related]
18. The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.
Wang N; Zhang Q; Jing X; Guo J; Huang H; Xu Z
Med Sci Monit; 2020 Mar; 26():e920137. PubMed ID: 32142504
[TBL] [Abstract][Full Text] [Related]
19. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
Wu X; Li W; Luo Z; Chen Y
Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
[TBL] [Abstract][Full Text] [Related]
20. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
